Ascend Wellness Holdings AAWH
OTC AAWH
$0.48 +0.02 (+5.47%)
As of: Aug 21, 2026 · 3:59 PM EDT

Ascend Wellness Holdings (AAWH) Cash from Financing Activities (2020 - 2026)

Ascend Wellness Holdings (AAWH) posted quarterly Cash from Financing Activities of -$592000.0 for Q1 2026, down 104.32% year-over-year from $13.7 million in Q1 2025, and up 48.48% quarter-over-quarter from -$1.1 million in Q4 2025.

Ascend Wellness Holdings (AAWH) Cash from Financing Activities (2020 - 2026) Analysis & Trends

Ascend Wellness Holdings' Cash from Financing Activities history runs 7 years deep, the most recent figure standing at -$592000.0 for Q1 2026.

  • In Q1 2026, Cash from Financing Activities fell 104.32% year-over-year to -$592000.0; the TTM figure through Mar 2026 stood at -$9.2 million (down 78.29% YoY), while the FY2025 annual figure was $5.1 million, up 125.09% from the prior year.
  • Cash from Financing Activities for Q1 2026 stood at -$592000.0, up from -$1.1 million in the prior quarter.
  • The five-year high for Cash from Financing Activities was $54.7 million in Q2 2022, with the low at -$14.0 million in Q2 2025.
  • The 5-year median for Cash from Financing Activities is -$1.1 million (2025), against an average of $2.3 million.
  • The sharpest annual moves came in 2022 and 2024: Cash from Financing Activities soared 1070.0% in 2022, then slumped 6947.95% in 2024.
  • Ascend Wellness Holdings' Cash from Financing Activities stood at $18.5 million in 2022, then slumped by 99.61% to $73000.0 in 2023, then plunged by 6947.95% to -$5.0 million in 2024, then soared by 77.02% to -$1.1 million in 2025, then soared by 48.48% to -$592000.0 in 2026.
  • Business Quant data shows AAWH's Cash from Financing Activities at -$592000.0 in Q1 2026, -$1.1 million in Q4 2025, and $6.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn -1.00 Mn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn -813.00 Mn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn -1.13 Bn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn 122.40 Mn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn -1.24 Bn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn 63.40 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn -74.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - -
10 Ascend Wellness Holdings 97.42 Mn 30.42 Mn 45.49 Mn -3.28 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -3.28 Mn
Jun 30, 2026 -3.28 Mn
Mar 31, 2026 -592,000.00
Mar 31, 2026 -592,000.00
Dec 31, 2025 -1.15 Mn
Dec 31, 2025 -1.15 Mn
Sep 30, 2025 6.54 Mn
Sep 30, 2025 6.54 Mn
Jun 30, 2025 -13.98 Mn
Jun 30, 2025 -13.98 Mn
Mar 31, 2025 13.69 Mn
Mar 31, 2025 13.69 Mn
Dec 31, 2024 -5.00 Mn
Dec 31, 2024 -5.00 Mn
Sep 30, 2024 -9.27 Mn
Sep 30, 2024 -9.27 Mn
Jun 30, 2024 -4.57 Mn
Jun 30, 2024 -4.57 Mn
Mar 31, 2024 -1.52 Mn
Mar 31, 2024 -1.52 Mn